Search Results - Samra Turajlic

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Clinical and immunologic implications of COVID-19 in patients with melanoma and renal cell carcinoma receiving immune checkpoint inhibitors by John Haanen, Samra Turajlic, Igor Puzanov, Paul C Lorigan, Benjamin Switzer

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  2. 2

    Generation of TWO iPSC lines (CRICKi009-A; CRICKi010-A) from patients with type 1 von Hippel-Lindau (VHL) and histopathologically confirmed renal cell carcinoma (RCC) by Liani G. Devito, Eugénie S. Lim, Samuel M. O’Toole, Scott T.C. Shepherd, Daqi Deng, Hugang Feng, Taja Barber, William M. Drake, Samra Turajlic, Lyn Healy

    Published in Stem Cell Research (2024-12-01)
    Get full text
    Article


  3. 3

    1312 Identification and validation of immunogenic clonal neoantigens for personalized therapies by Andrew Craig, Martin Forster, Samra Turajlic, Sergio A Quezada, Katy Newton, Karl Peggs, Fong Chan, Karen Matthews, Theres Oakes, Gareth Wilson, Elizabeth Larose Cadieux, Max Salm, Hugh O’Brien

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  4. 4

    Oral beclomethasone dipropionate is an effective treatment for immune checkpoint inhibitor induced colitis by Hajir Ibraheim, Sophie Papa, Nick Powell, James L Alexander, Polychronis Pavlidis, James Larkin, Samra Turajlic, Andrew Furness, Julian P Teare, Andrew Wotherspoon, Camellia Richards, Nikki Hunter, Lisa Pickering, Ally Speight, Ben Shum

    Published in Journal for ImmunoTherapy of Cancer (2022-09-01)
    Get full text
    Article


  5. 5

    Therapeutic inhibition of monocyte recruitment prevents checkpoint inhibitor-induced hepatitis by Nick Powell, Mark R Thursz, Kevin J Woollard, James Larkin, Samra Turajlic, Stephen R Atkinson, Robert D Goldin, Evangelos Triantafyllou, Lucia A Possamai, Charalambos G Antoniades, Cathrin L C Gudd, Eoin Mitchell, Marie-Anne Mawhin

    Published in Journal for ImmunoTherapy of Cancer (2024-04-01)
    Get full text
    Article


  6. 6

    Interpretability of radiomics models is improved when using feature group selection strategies for predicting molecular and clinical targets in clear-cell renal cell carcinoma: ins... by Matthew R. Orton, Evan Hann, Simon J. Doran, Scott T. C. Shepherd, Derfel Ap Dafydd, Charlotte E. Spencer, José I. López, Víctor Albarrán-Artahona, Francesca Comito, Hannah Warren, Joshua Shur, Christina Messiou, James Larkin, Samra Turajlic, on behalf of the TRACERx Renal Consortium, Dow-Mu Koh

    Published in Cancer Imaging (2023-08-01)
    Get full text
    Article


  7. 7

    Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma by Richard Culliford, Samuel E. D. Lawrence, Charlie Mills, Zayd Tippu, Daniel Chubb, Alex J. Cornish, Lisa Browning, Ben Kinnersley, Robert Bentham, Amit Sud, Husayn Pallikonda, The Renal Cancer Genomics England Consortium, Anna Frangou, Andreas J. Gruber, Kevin Litchfield, David Wedge, James Larkin, Samra Turajlic, Richard S. Houlston

    Published in Nature Communications (2024-07-01)
    Get full text
    Article


  8. 8

    Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab by Hajir Ibraheim, Sophie Papa, Nick Powell, James L Alexander, James Larkin, Samra Turajlic, Andrew Furness, Julian P Teare, Paul Nathan, Dharmisha Chauhan, David J Pinato, Jessica Little, Raguprakash Ratnakumaran, Bhavisha Sheth, Muhammad Saheb Khan, Camellia Richards, Nikki Hunter, Kathleen McHugh, Julia Choy, Shanthini M Crusz, Lisa Pickering, Ally Speight, Anand Sharma

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


Search Tools: